Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Butyrate for Acute GVHD Prevention in HSCT
NCT05808985Phase 2Unknown
- Sponsor
- Soonchunhyang University Hospital
- Start
- Sep 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium butyrate in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Soonchunhyang University Hospital. Status: unknown.
02
Drugs
sodium butyrate
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT05808985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05808985.